Michael S Hearne
CIK 1759910 · Chief Financial Officer · last filed 2026-05-20
Michael S Hearne is a Chief Financial Officer who has filed 107 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for AUPH, was dated May 20, 2026. Across all open-market trades the lifetime net is +$12.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.84M
3
107
$12.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Chief Financial Officer | 116,144 | $15.82 | $1.84M | $0 | 1 | 2026-05-20 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Chief Financial Officer | 9,618,120 | $6.22 | $59.82M | $0 | 45 | 2022-07-05 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Chief Financial Officer | 15,517,186 | $1.12 | $17.38M | $12.78M | 59 | 2021-03-17 |
Recent Filings
107 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | AUPH | Grant (A) | +116,144 | $0 | EDGAR |
| 2022-08-24 | — | Mixed | — | $0 | |
| 2022-08-24 | — | Mixed | −9,618,120 | -$59.92M | |
| 2022-07-05 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +236 | $640 | EDGAR |
| 2022-06-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +236 | $642 | EDGAR |
| 2022-06-02 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +189 | $644 | EDGAR |
| 2022-05-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +188 | $641 | EDGAR |
| 2022-05-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +185 | $642 | EDGAR |
| 2022-04-18 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +173 | $643 | EDGAR |
| 2022-04-04 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +177 | $642 | EDGAR |